Floatz logo

Therapeutic Asset Ratings

174 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Bcma Targeted Car T-Cells
Acute Lymphoblastic Leukemia
Zhejiang UniversityEarly P1C (38)
cd19/bcma-targeted car-t cells
Acute Lymphoblastic Leukemia, in Relapse
Zhejiang UniversityEarly P1C (38)
cd5-targeted car-t cells
T-Lymphoblastic Lymphoma
Zhejiang UniversityEarly P1C (38)
Decitabine
Li-Fraumeni Syndrome
Zhejiang UniversityEarly P1C (38)
Anti-Cd70-Car-T Cells
Head and Neck Squamous Cell Carcinoma
Zhejiang UniversityP1C (37)
C-Car031
Hepatocellular Carcinoma
Zhejiang UniversityP1C (37)
cht101
Head And Neck Squamous Cell Carcinoma
Zhejiang UniversityP1C (37)
cht101
Renal Cell Carcinoma
Zhejiang UniversityP1C (37)
Anti-Cd70-Car-T Cells
Advanced Solid Tumor
Zhejiang UniversityP1C (36)
Anti-Cd70-Car-T Cells
Ovarian Cancer
Zhejiang UniversityP1C (36)
cht101
Cancer
Zhejiang UniversityP1C (36)
cht101
Ovarian Cancer
Zhejiang UniversityP1C (36)
OL-101
Plasma Cell Myeloma
Zhejiang UniversityP1C (36)
OriC321
Plasma Cell Myeloma
Zhejiang UniversityP1C (36)
Universal Chimeric Natural Killer Receptor Modified T-Cells
Cancer
Zhejiang UniversityP1C (36)
wbc100 bid
Neoplasm
Zhejiang UniversityP1C (36)
wbc100 qd
Neoplasm
Zhejiang UniversityP1C (36)
Anti Cd30 Car-T Cell
Diffuse Large B-Cell Lymphoma
Zhejiang UniversityEarly P1C (36)
CD38 CAR T-cells
Acute Myeloid Leukemia
Zhejiang UniversityEarly P1C (36)
cd70-targeting car-t cells
Non-Hodgkin Lymphoma
Zhejiang UniversityEarly P1C (36)
cdh17 car-t
Biliary Tract Cancer
Zhejiang UniversityEarly P1C (36)
cdh17 car-t
Colorectal Carcinoma
Zhejiang UniversityEarly P1C (36)
Fast Laco-Stim Cdh17 Car-T
Biliary Tract Cancer
Zhejiang UniversityEarly P1C (36)
Fast Laco-Stim Cdh17 Car-T
Colorectal Carcinoma
Zhejiang UniversityEarly P1C (36)
Syncar-100
B-Cell Acute Lymphoblastic Leukemia
Zhejiang UniversityEarly P1C (36)
Showing 126 to 150 of 174 assets
PreviousPage 6 of 7Next